AVDOX-CV

AVDOX-CV tablets deliver a potent one-two punch against tough bacterial infections that require an enhanced approach:

• Cefpodoxime (200 mg): A versatile cephalosporin antibiotic that effectively targets a wide array of bacteria responsible for causing infections in the respiratory tract, skin, and urinary system.
• Clavulanate Potassium (125 mg): A beta-lactamase inhibitor that extends the antibacterial efficacy of Cefpodoxime by combating antibiotic resistance, making it a powerful option for treating infections that are difficult to eradicate.

By combining Cefpodoxime with Clavulanate Potassium, AVDOX-CV can tackle a broader range of pathogens, including those that produce beta-lactamase, an enzyme that would otherwise render many antibiotics ineffective. This combination is particularly useful in treating more severe infections where resistance is a concern, ensuring a higher chance of successful treatment outcomes.

Packaged with a Mono Carton, AVDOX-CV tablets are well-protected to maintain their integrity and potency from the point of manufacture to the moment of consumption. Ideal for patients facing complex infections, AVDOX-CV provides a robust solution to support a quick and effective recovery.